As an emerging topic of discussion within clinical diagnosis and drug discovery, biomarker research and developments are set to expand the scope of relevant clinical endpoints. During the three-day intensive Biomarker workshop, participants will gain a basic understanding of the study of biomarkers, as well as major concepts within the field.

Instruction from leading industry experts will deliver biomarker research and theoretical concepts, as well as practical issues involved in conducting drug discovery related biomarker research and disease related biomarker identification. Workshop participants will learn various biomarker research model systems and tools while learning the criteria required for identifying biomarkers in different diseases.

Topics may include:

  • Biomarker requirements, classification and criteria for evaluating potential markers.
  • The practice of sample collection and quality control for a biomarker study in conjunction with epidemiological studies, including design, analysis and more.
  • Ethical and legal concerns.
  • Tools including flow cytometry, DNA arrays, gene expression arrays and proteomics.
  • Biomarker in diseases, including cancer and autoimmune disease, such as rheumatoid arthritis.
  • Biomarker in Drug Discovery in animal models, in vitro diagnostics and surrogate and endpoint biomarker.
Speakers:
  • Jelveh Lameh, Ph.D., Head of Operations and Regulatory Affairs, Navigate BioPharma Services Inc.
  • Hua Gong, Ph.D., Sr. Director, Genomic Biomarker Solutions, Navigate BioPharma Services Inc.
  • Reinhold Pollner, Ph.D., Director, Genomic Biomarker Solutions, Navigate BioPharma Services Inc.
  • Naveen Dakappagari, Ph.D., Sr. Director, Protein Biomarker Solutions, Navigate BioPharma Services Inc.
  • Chad Ray, Ph.D., Senior Scientific Director-Global Therapeutics Research Pharmacokinetics, Dynamics, Metabolism, Zoetis
     

Course Number: BIOL-40258
Credit: 3.00 unit(s)
Related Certificate Programs: Drug Discovery and DevelopmentIn Vitro Diagnostics